Patent · US Active

Anti-pro/latent-Myostatin antibodies and uses thereof

US10751413B2 · kind B2 · utility

6Cited by
6References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2016
Grant dateAug 25, 2020
Priority date—
Expiry dateJan 19, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Aspects of the present disclosure relate to antibodies that specifically bind proMyostatin and/or latent Myostatin and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.